Literature DB >> 22675201

Autoreactive preplasma cells break tolerance in the absence of regulation by dendritic cells and macrophages.

Mileka R Gilbert1, Nikki J Wagner, Shannon Z Jones, Amanda B Wisz, Jose R Roques, Kristen N Krum, Sang-Ryul Lee, Volker Nickeleit, Chrys Hulbert, James W Thomas, Stephen B Gauld, Barbara J Vilen.   

Abstract

The ability to induce Ab responses to pathogens while maintaining the quiescence of autoreactive cells is an important aspect of immune tolerance. During activation of TLR4, dendritic cells (DCs) and macrophages (MFs) repress autoantibody production through their secretion of IL-6 and soluble CD40L (sCD40L). These soluble mediators selectively repress B cells chronically exposed to Ag, but not naive cells, suggesting a means to maintain tolerance during TLR4 stimulation, yet allow immunity. In this study, we identify TNF-α as a third repressive factor, which together with IL-6 and CD40L account for nearly all the repression conferred by DCs and MFs. Similar to IL-6 and sCD40L, TNF-α did not alter B cell proliferation or survival. Instead, it reduced the number of Ab-secreting cells. To address whether the soluble mediators secreted by DCs and MFs functioned in vivo, we generated mice lacking IL-6, CD40L, and TNF-α. Compared to wild-type mice, these mice showed prolonged anti-nuclear Ab responses following TLR4 stimulation. Furthermore, adoptive transfer of autoreactive B cells into chimeric IL-6(-/-) × CD40L(-/-) × TNF-α(-/-) mice showed that preplasma cells secreted autoantibodies independent of germinal center formation or extrafollicular foci. These data indicate that in the absence of genetic predisposition to autoimmunity, loss of endogenous IL-6, CD40L, and TNF-α promotes autoantibody secretion during TLR4 stimulation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22675201      PMCID: PMC3392546          DOI: 10.4049/jimmunol.1102973

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  66 in total

1.  Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis.

Authors:  M Linker-Israeli; R J Deans; D J Wallace; J Prehn; T Ozeri-Chen; J R Klinenberg
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

2.  Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury.

Authors:  D C Brennan; M A Yui; R P Wuthrich; V E Kelley
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

3.  Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis.

Authors:  J M Boswell; M A Yui; D W Burt; V E Kelley
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

4.  Humoral immune responses in CD40 ligand-deficient mice.

Authors:  B R Renshaw; W C Fanslow; R J Armitage; K A Campbell; D Liggitt; B Wright; B L Davison; C R Maliszewski
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

5.  Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro.

Authors:  N Hirohashi; D C Morrison
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

6.  Atherosclerosis and plasma and liver lipids in nine inbred strains of mice.

Authors:  P M Nishina; J Wang; W Toyofuku; F A Kuypers; B Y Ishida; B Paigen
Journal:  Lipids       Date:  1993-07       Impact factor: 1.880

7.  Tumor necrosis factor in the serum of patients with systemic lupus erythematosus.

Authors:  C P Maury; A M Teppo
Journal:  Arthritis Rheum       Date:  1989-02

8.  The differentiation of human memory B cells into specific antibody-secreting cells is CD40 independent.

Authors:  A Silvy; C Lagresle; C Bella; T Defrance
Journal:  Eur J Immunol       Date:  1996-03       Impact factor: 5.532

9.  Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction.

Authors:  D Gray; P Dullforce; S Jainandunsing
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

10.  Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response.

Authors:  M Pasparakis; L Alexopoulou; V Episkopou; G Kollias
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

View more
  7 in total

1.  Altered toll-like receptor responsiveness underlies a dominant heritable defect in B cell tolerance in autoimmune New Zealand Black mice.

Authors:  Amy G Clark; Elizabeth S Buckley; Mary H Foster
Journal:  Eur J Immunol       Date:  2018-01-19       Impact factor: 5.532

2.  B Cell-Extrinsic Myd88 and Fcer1g Negatively Regulate Autoreactive and Normal B Cell Immune Responses.

Authors:  Rebecca A Sweet; Kevin M Nickerson; Jaime L Cullen; Yujuan Wang; Mark J Shlomchik
Journal:  J Immunol       Date:  2017-06-28       Impact factor: 5.422

3.  BAFF Induces Tertiary Lymphoid Structures and Positions T Cells within the Glomeruli during Lupus Nephritis.

Authors:  SunAh Kang; Yuri Fedoriw; Ethan K Brenneman; Young K Truong; Kristine Kikly; Barbara J Vilen
Journal:  J Immunol       Date:  2017-02-24       Impact factor: 5.422

4.  Myeloid cells limit production of antibody-secreting cells after immunization in the lymph node.

Authors:  David R Fooksman; Michel C Nussenzweig; Michael L Dustin
Journal:  J Immunol       Date:  2013-12-27       Impact factor: 5.422

Review 5.  Autoimmunity in 2012.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 6.  Roles of B Cell-Intrinsic TLR Signals in Systemic Lupus Erythematosus.

Authors:  Kongyang Ma; Jingyi Li; Yongfei Fang; Liwei Lu
Journal:  Int J Mol Sci       Date:  2015-06-09       Impact factor: 5.923

7.  Silica Exposure Differentially Modulates Autoimmunity in Lupus Strains and Autoantibody Transgenic Mice.

Authors:  Mary H Foster; Jeffrey R Ord; Emma J Zhao; Anastasiya Birukova; Lanette Fee; Francesca M Korte; Yohannes G Asfaw; Victor L Roggli; Andrew J Ghio; Robert M Tighe; Amy G Clark
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.